ProQR Therapeutics (PRQR) EBT Margin (2013 - 2026)
ProQR Therapeutics (PRQR) posted quarterly EBT Margin of 658.29% for Q1 2026, down 42704.0% year-on-year from N/an in Q1 2025, and down 207.9% on a QoQ basis from 213.8% in Q4 2025.
ProQR Therapeutics (PRQR) EBT Margin (2013 - 2026) Analysis & Trends
ProQR Therapeutics (PRQR) has reported EBT Margin for 14 consecutive years, with 658.29% the latest figure, recorded in Q1 2026.
- Quarterly EBT Margin fell 42704.0% year-over-year to 658.29% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 347.04% (down 18495.0% YoY) and the FY2025 annual result came in at 272.03%, down 12413.0% from the prior year.
- EBT Margin retreated to 658.29% in Q1 2026 per PRQR's latest filing, from 213.8% in the prior quarter.
- Over the last five years, EBT Margin for PRQR reached as high as 45.87% in Q2 2024 and fell as low as 2854.42% in Q3 2022.
- A 5-year average of 733.51% and a median of 381.89% in 2025 frame the typical range for EBT Margin.
- The largest YoY upside for EBT Margin was 577537 bps in 2022 against a maximum downside of 114448 bps in 2022.
- Year by year, EBT Margin stood at 1847.22% in 2022, then jumped by 89 bps to 207.06% in 2023, then slipped by 4 bps to 216.04% in 2024, then advanced by 1 bps to 213.8% in 2025, then plunged by 208 bps to 658.29% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 658.29%, 213.8%, and 381.89% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | -658.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -658.29% |
| Dec 31, 2025 | -213.80% |
| Sep 30, 2025 | -381.89% |
| Jun 30, 2025 | -318.60% |
| Mar 31, 2025 | -231.25% |
| Dec 31, 2024 | -216.04% |
| Sep 30, 2024 | -210.98% |
| Jun 30, 2024 | -45.87% |
| Mar 31, 2024 | -172.02% |
| Dec 31, 2023 | -207.06% |
| Sep 30, 2023 | -398.61% |
| Jun 30, 2023 | -665.48% |
| Mar 31, 2023 | -1,351.91% |
| Dec 31, 2022 | -1,847.22% |
| Sep 30, 2022 | -2,854.42% |
| Jun 30, 2022 | -1,447.63% |
| Mar 31, 2022 | -1,248.67% |
| Dec 31, 2021 | -7,622.59% |
| Sep 30, 2021 | -1,724.08% |
| Jun 30, 2021 | -6,460.91% |